Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6306877A · kind A · utility
2Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2000 |
| Grant date | Oct 23, 2001 |
| Priority date | — |
| Expiry date | Sep 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention involves compounds having the following structure ##STR1## as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.